Competent Cells Market– Global Opportunity Analysis And Industry Forecast (2018-2023)
Succeeding an extensive secondary and primary research on competent cells and in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraint, opportunities, and challenges in the market dynamics
(EMAILWIRE.COM, April 20, 2018 ) The global competent cells market will grow at a CAGR of 10% during the forecast period to reach USD 2,318.6 million by 2023, primarily driven by “growing demand for recombinant proteins and molecular cloned products, advancement in molecular cloning research with emergence of new technologies, various government initiatives, and growing funding for life science research,” Meticulous Research™ noted in a press release today.
Request Sample Report: https://tinyurl.com/ybnc3b52
The report notes that cloned competent cells held the largest share, owing to “their rising adoption in research with increasing feasibility of genetic therapy, growing need for rapid diagnosis & treatment, favorable government support for cloning based research in various countries, and rising availability of sophisticated instruments and technology.”
Geographically, North America held the largest share in this market, due to ”its well-established healthcare system, higher acceptance of advanced technologies, raising non-communicable diseases & related rise in pharmaceutical research & development, increase in cloning based research, favorable reimbursement scenario, and presence of key players in this market.”
The key players in this market are Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck & Company, Inc., Illumina, Inc., Promega Corporation, New England Biolabs, OriGene Technologies, Inc., Zymo Research Corporation, Scarab Genomics, LLC, Meridian Bioscience, Inc., Delphi Genetics S.A., Qiagen N.V., Cell Applications, Inc., GenScript Biotech Corporation, and Takara Holdings Inc.
Download Free Brochure @ https://tinyurl.com/ydbas5t3
Report Scope:
Type:
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells
Treatment:
Chemically Competent Cells
Electrocompetent Cells
Application:
Cloning
Subcloning & Routine Cloning
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Phage Display Library production
Protein Expression
Others
Single Stranded DNA Preparation
Mutagenesis Study
Large Plasmid Transformation
Lentiviral Vector Production
End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations
Geographic scope:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Turkey
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
South Korea
Australia
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa
Enquire before buying: https://tinyurl.com/y9vh4lsl
About Meticulous Research™
Meticulous Research™ is founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Contact Info:
Viren Shrivastava
AVP- Global Sales and Marketing
Meticulous Research™
Email: viren@meticulousresearch.com
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)
Request Sample Report: https://tinyurl.com/ybnc3b52
The report notes that cloned competent cells held the largest share, owing to “their rising adoption in research with increasing feasibility of genetic therapy, growing need for rapid diagnosis & treatment, favorable government support for cloning based research in various countries, and rising availability of sophisticated instruments and technology.”
Geographically, North America held the largest share in this market, due to ”its well-established healthcare system, higher acceptance of advanced technologies, raising non-communicable diseases & related rise in pharmaceutical research & development, increase in cloning based research, favorable reimbursement scenario, and presence of key players in this market.”
The key players in this market are Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck & Company, Inc., Illumina, Inc., Promega Corporation, New England Biolabs, OriGene Technologies, Inc., Zymo Research Corporation, Scarab Genomics, LLC, Meridian Bioscience, Inc., Delphi Genetics S.A., Qiagen N.V., Cell Applications, Inc., GenScript Biotech Corporation, and Takara Holdings Inc.
Download Free Brochure @ https://tinyurl.com/ydbas5t3
Report Scope:
Type:
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells
Treatment:
Chemically Competent Cells
Electrocompetent Cells
Application:
Cloning
Subcloning & Routine Cloning
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Phage Display Library production
Protein Expression
Others
Single Stranded DNA Preparation
Mutagenesis Study
Large Plasmid Transformation
Lentiviral Vector Production
End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations
Geographic scope:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Turkey
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
South Korea
Australia
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa
Enquire before buying: https://tinyurl.com/y9vh4lsl
About Meticulous Research™
Meticulous Research™ is founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Contact Info:
Viren Shrivastava
AVP- Global Sales and Marketing
Meticulous Research™
Email: viren@meticulousresearch.com
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)
Contact Information:
Meticulous Research™
Viren Shrivastava
Tel: +91 744-7780008
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Meticulous Research™
Viren Shrivastava
Tel: +91 744-7780008
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results